Effects of Pump versus Twice-Daily Injection Delivery of Synthetic Parathyroid Hormone 1-34 in Children with Severe Congenital Hypoparathyroidism

2014/06/16 by Karen K. Winer, Kara A. Fulton, Paul S. Albert +1 · 125 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Calcium #Endocrinology #Genetic Syndromes and Imprinting #Hormone #Hypoparathyroidism #Internal medicine #Medicine #Parathyroid Disorders and Treatments #Parathyroid hormone #Thyroid and Parathyroid Surgery

paper · open access · doi:10.1016/j.jpeds.2014.04.060

published in The Journal of Pediatrics 165(3), 556-563.e1 (Elsevier BV)

openalex publication_date 2014/06/16 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04

Cited by

• Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes
• Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop
• PTH(1-84) replacement therapy for the treatment of hypoparathyroidism. [europepmc]
• PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization. [europepmc]
• Pharmacodynamic Actions of a Long-Acting PTH Analog (LA-PTH) in Thyroparathyroidectomized (TPTX) Rats and Normal Monkeys. [europepmc]
• Management of Hypoparathyroidism: Present and Future. [europepmc]
• Simulated Interventions to Ameliorate Age-Related Bone Loss Indicate the Importance of Timing. [europepmc]
• Prolonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment. [europepmc]
• Review of Hypoparathyroidism. [europepmc]
• Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism. [europepmc]
• Impact of intercurrent illness on calcium homeostasis in children with hypoparathyroidism: a case series. [europepmc]
• Optimal dosing and delivery of parathyroid hormone and its analogues for osteoporosis and hypoparathyroidism - translating the pharmacology. [europepmc]
• Does PTH Replacement Therapy Improve Quality of Life in Patients With Chronic Hypoparathyroidism? [europepmc]
• Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism. [europepmc]
• Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism. [europepmc]
• Continuous rhPTH (1-34) treatment in chronic hypoparathyroidism. [europepmc]
• Recent advances in understanding and managing hypoparathyroidism. [europepmc]
• Recombinant human parathyroid hormone (1-84) is effective in CASR-associated hypoparathyroidism. [europepmc]
• The challenges of post-bariatric surgery hypocalcaemia in pre-existing hypoparathyroidism. [europepmc]
• Chronic hypoparathyroidism and treatment with teriparatide. [europepmc]
• MANAGEMENT OF ENDOCRINE DISEASE: Postsurgical hypoparathyroidism: current treatments and future prospects for parathyroid allotransplantation. [europepmc]
• Safety and Efficacy of Oral Human Parathyroid Hormone (1-34) in Hypoparathyroidism: An Open-Label Study. [europepmc]
• PTH Infusion for Seizures in Autosomal Dominant Hypocalcemia Type 1. [europepmc]
• Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report. [europepmc]
• Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials. [europepmc]
• Management of Hypoparathyroidism. [europepmc]
• Treatment of Hypoparathyroidism by Re-Establishing the Effects of Parathyroid Hormone. [europepmc]